EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Elevated cholesterol in ATAD3 mutants is a compensatory mechanism that leads to membrane cholesterol aggregation

Mikel Muñoz-Oreja iD, Abigail Sandoval, Ove Bruland, Diego Perez-Rodriguez, Uxoa Fernandez-Pelayo iD, Amaia Lopez de Arbina iD, Marina Villar-Fernandez, Haizea Hernández-Eguiazu, Ixiar Hernández, Yohan Park, Leire Goicoechea, Nerea Pascual-Frías und 14 weitere

Brain · 2024

DOI: 10.1093/brain/awae018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Mikel Muñoz-Oreja und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Biogipuzkoa Health Research Institute, 20014 San Sebastian, Spain. Hauptthemen laut MEDLINE: Cholesterol, ATPases Associated with Diverse Cellular Activities, Lysosomes, Mutation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MRF_, Medical Research Council, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant cholesterol metabolism causes neurological disease and neurodegeneration, and mitochondria have been linked to perturbed cholesterol homeostasis via the study of pathological mutations in the ATAD3 gene cluster. However, whether the cholesterol changes were compensatory or contributory to the disorder was unclear, and the effects on cell membranes and the wider cell were also unknown. Using patient-derived cells, we show that cholesterol perturbation is a conserved feature of pathological ATAD3 variants that is accompanied by an expanded lysosome population containing membrane whorls characteristic of lysosomal storage diseases. Lysosomes are also more numerous in Drosophila neural progenitor cells expressing mutant Atad3, which exhibit abundant membrane-bound cholesterol aggregates, many of which co-localize with lysosomes. By subjecting the Drosophila Atad3 mutant to nutrient restriction and cholesterol supplementation, we show that the mutant displays heightened cholesterol dependence. Collectively, these findings suggest that elevated cholesterol enhances tolerance to pathological ATAD3 variants; however, this comes at the cost of inducing cholesterol aggregation in membranes, which lysosomal clearance only partly mitigates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolATPases Associated with Diverse Cellular ActivitiesLysosomesMutationMembrane ProteinsAnimalsHumansDrosophilaCell MembraneMitochondrial ProteinsDrosophila Proteins

Stichwörter der Autor:innen

AAA+ ATPaseATAD3cholesterol disorderslysosomal storage disorderslysosomesmitochondrial disease

Substanzen

CholesterolATPases Associated with Diverse Cellular ActivitiesATAD3A protein, humanMembrane ProteinsMitochondrial ProteinsDrosophila Proteins

Autor:innen und Institutionen

  • Department of Neurosciences, Biogipuzkoa Health Research Institute, 20014 San Sebastian, Spain.
  • University of the Basque Country-Bizkaia Campus, 48940 Bilbao, Spain.
  • CIBERNED (Center for Networked Biomedical Research on Neurodegenerative Diseases, Ministry of Economy and Competitiveness, Institute Carlos III), 28031 Madrid, Spain.
  • Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
  • Department of Medical Genetics, Haukeland University Hospital, Bergen 5021, Norway.
  • Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Royal Free Campus, London NW3 2PF, UK.

ORCID-Profile: Mikel Muñoz-Oreja, Uxoa Fernandez-Pelayo, Amaia Lopez de Arbina, Matthew E Gegg, Antonella Spinazzola, Ian J Holt

Förderung

  • MRF_
  • Medical Research Council
  • NIH HHS
  • NINDS NIH HHS
  • University of the Basque Country
  • Basque Government’s IKUR strategy Neurodegenprot project
  • Basque Government
  • Spanish Ministry of Health

Zitieren

APA

Muñoz-Oreja, M., Sandoval, A., Bruland, O., Perez-Rodriguez, D., Fernandez-Pelayo, U., de Arbina, A. L., Villar-Fernandez, M., Hernández-Eguiazu, H., Hernández, I., Park, Y., Goicoechea, L., Pascual-Frías, N., Garcia-Ruiz, C., Fernandez-Checa, J., Martí-Carrera, I., Gil-Bea, F. J., Hasan, M. T., Gegg, M. E., Bredrup, C., …, & Holt, I. J. (2024). Elevated cholesterol in ATAD3 mutants is a compensatory mechanism that leads to membrane cholesterol aggregation. Brain. https://doi.org/10.1093/brain/awae018

Vancouver

Muñoz-Oreja M, Sandoval A, Bruland O, Perez-Rodriguez D, Fernandez-Pelayo U, de Arbina AL, et al. Elevated cholesterol in ATAD3 mutants is a compensatory mechanism that leads to membrane cholesterol aggregation. Brain. 2024. doi:10.1093/brain/awae018

BibTeX
@article{MuozOreja2024,
  author = {Muñoz-Oreja, Mikel and Sandoval, Abigail and Bruland, Ove and Perez-Rodriguez, Diego and Fernandez-Pelayo, Uxoa and de Arbina, Amaia Lopez and Villar-Fernandez, Marina and Hernández-Eguiazu, Haizea and Hernández, Ixiar and Park, Yohan and Goicoechea, Leire and Pascual-Frías, Nerea and Garcia-Ruiz, Carmen and Fernandez-Checa, Jose and Martí-Carrera, Itxaso and Gil-Bea, Francisco Javier and Hasan, Mazahir T and Gegg, Matthew E and Bredrup, Cecilie and Knappskog, Per-Morten and Gereñu-Lopetegui, Gorka and Varhaug, Kristin N and Bindoff, Laurence A and Spinazzola, Antonella and Yoon, Wan Hee and Holt, Ian J},
  title = {Elevated cholesterol in ATAD3 mutants is a compensatory mechanism that leads to membrane cholesterol aggregation},
  journal = {Brain},
  year = {2024},
  doi = {10.1093/brain/awae018}
}
Kostenlos starten →